Open an Account
search icon
1
NOTIFICATIONS
Best Algo trading app in India
Bigul

Sun Pharma Advanced Research Company Ltd - 532872 - Report Of Proceedings Of Extra Ordinary General Meeting Of The Company Held On 8Th June, 2021

 The Extra-Ordinary General Meeting (EGM) of Sun Pharma Advanced Research Company Ltd. was held on Tuesday, 8th June 2021 at 4:00 p.m. IST through Video Conferencing ('VC') / Other Audio-Visual Means ('OAVM'). Pursuant to regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015 the proceedings of the Extra-Ordinary General Meeting is enclosed herewith for your record & dissemination.
09-06-2021
Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Corrigendum - 2 To Notice Of The Extra-Ordinary General Meeting Of The Company On Tuesday, 8Th June 2021 At 04.00 P.M.

 With reference to the Notice convening EGM on 8th June 2021 at 04.00 p.m. IST, through ('VC')/ ('OAVM'), the Company has issued second 'clarificatory' Corrigendum to the shareholders, which is enclosed herewith for your record & dissemination. Please note that the Corrigendum - 2 is being issued as a measure of abundant precaution with limited intent to clarify on disclosures relating to non-applicability of wilful defaulter related clause and to rectify an inadvertent typographical error pertaining to total pre-issue shareholding of public shareholders mentioned in the EGM Notice This communication should be read along with the original EGM Notice dated 12th May 2021 as updated by 1st Corrigendum dated May 25, 2021 which was submitted to the Exchange along with the above mentioned letter. The EGM Notice along with the Corrigendum is also available on the website of the Company and can be accessed using the link: https://www.sparc.life/announcements-disclosures.
04-06-2021
Bigul

Sun Pharma Advanced Research Company Ltd - 532872 - Disclosure Of Related Party Transactions - March 2021

 Dear Sir/ Madam, In compliance with Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) (Amendments) Regulations, 2018, we hereby submit the Related Party Transactions on consolidated basis, in accordance with the applicable accounting standards, for the half year ended 31st March 2021. This is for your information and record.
02-06-2021
Bigul

Sun Pharma Advanced Research Company Ltd - 532872 - Corrigendum To Notice Of The Extra-Ordinary General Meeting Of The Company On Tuesday, 8Th June 2021 At 04.00 P.M.

 With reference to the Notice convening Extra-Ordinary General Meeting of the Company on Tuesday, 8th June 2021 at 04.00 p.m. IST, through Video Conferencing ('VC')/ Other Audio Visual Means ('OAVM'), ('EGM Notice') the Company has issued a 'clarificatory' Corrigendum to the shareholders, which is enclosed herewith for your record & dissemination. Please note that the Corrigendum is being issued as a measure of abundant precaution with limited intent to clarify on disclosures relating to ultimate beneficial owners made in the table of para 6 of the explanatory statement of the EGM Notice. This communication should be read along with the original EGM Notice dated 12th May 2021 which was submitted to the Exchange along with the above mentioned letter. The EGM Notice along with the Corrigendum is also available on the website of the Company and can be accessed using the link: https://www.sparc.life/announcements-disclosures. Inconvenience caused in this regard is deeply regretted.
26-05-2021

Dilip Shanghvi resigns as MD of SPARC: Here's what you need to know about him

 Dilip Shanghvi will continue to be SPARC's chairman and a non-executive director on the board.
26-05-2021
Bigul

Sun Pharma Advanced Research Company Ltd - 532872 - Outcome Of Board Meeting Held On 25Th May 2021 Clarifications.

 In view of various queries received by us consequent to our letter to stock exchange bearing no. SPARC/Sec/SE/2021-22/016 dated 25th May 2021 on 'Outcome of Board Meeting held on 25th May 2021', it is clarified that Mr. Dilip Shanghvi has voluntarily chosen to step down as the Managing Director of the Company, inter alia, as a measure of good corporate governance and to proactively comply with the requirements of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates separation of the role of Chairman & Managing Director/ Manager of the Company with effect from 1st April 2022.
25-05-2021
Bigul

Sun Pharma Advanced Research Company Ltd - 532872 - Outcome Of Board Meeting Held On 25Th May 2021

 Pursuant to regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we hereby inform you that, the Board of Directors of the Company at their meeting held 04:30 pm to 08:00 pm today, inter alia, took the following decisions: i.Mr. Dilip Shanghvi expressed his desire to step down and tendered his resignation asthe Managing Director of the Company with immediate effect, which was accepted bythe Board as recommended by the Nomination & Remuneration Committee. Mr. DilipShanghvi will continue to be associated with the Board in his capacity as a non-executive director and Chairman of the Company.ii.On recommendation of Nomination and Remuneration Committee, the Board hasappointed Mr. Anil Raghavan, as a Chief Executive Officer (CEO) and whole time keymanagerial personnel of the Company with immediate effect, for a term of five yearsi.e upto 24th May 2026, subject to approval of members in a General Meeting of theCompany.
25-05-2021
Bigul

Sun Pharma Advanced Research Company Ltd - 532872 - Notice Of The Extra-Ordinary General Meeting Of The Company

 Pursuant to Regulation 30 of the SEBI (LODR) Regulation, 2015, as amended and any other applicable provision, we are pleased to enclose herewith the Notice convening an EGM of the members of the Company to be held on Tuesday, 8th June 2021 at 04.00 p.m. IST ('EGM') through Video Conferencing / Other Audio-Visual Means which is also being dispatched electronically to those members whose email IDs are registered with the Company/ Link Intime India Private Limited ('Registrar and Transfer Agent' of the Company) or the Depositories. The electronic copy of the Notice is also available on the website of the Company i.e. www.sparc.life. The cut-off date for determining right to attend the EGM and voting rights of members shall be in proportion to their shares of the paid up equity share capital of the Company as on the cut-off date of Tuesday, 1st June 2021.
17-05-2021
Bigul

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Notice Of The Extra-Ordinary General Meeting Of The Company

 Pursuant to Regulation 30 of the SEBI (LODR) Regulation, 2015, as amended and any other applicable provision, we are pleased to enclose herewith the Notice convening an EGM of the members of the Company to be held on Tuesday, 8th June 2021 at 04.00 p.m. IST ('EGM') through Video Conferencing / Other Audio-Visual Means which is also being dispatched electronically to those members whose email IDs are registered with the Company/ Link Intime India Private Limited ('Registrar and Transfer Agent' of the Company) or the Depositories. The electronic copy of the Notice is also available on the website of the Company i.e. www.sparc.life. The cut-off date for determining right to attend the EGM and voting rights of members shall be in proportion to their shares of the paid up equity share capital of the Company as on the cut-off date of Tuesday, 1st June 2021.
17-05-2021
Bigul

Sun Pharma Advanced Research Company Ltd - 532872 - Outcome Of Board Meeting Held On 17Th May 2021

 The Board of Directors of the Company at their meeting held from 06:00 pm to 09:15 pm today, inter alia, took the following decisions: i. Took on record and duly approved the Audited Financial Results of the Company for the quarter and year ended 31st March 2021 which is enclosed herewith along with the Auditors' Report on the Financial Statements of the Company for the Financial Year ended 31st March 2021 as Annexure 1. In terms of second proviso to regulation 33(3)(d) of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, a declaration by CFO confirming that the Auditors have given an Unmodified Opinion on the Annual Audited Financial Results of the Company for the financial year ended 31st March 2021 is also enclosed as Annexure 2. ii. Accepted the resignation of Mr. Debashis Dey as the Company Secretary and Compliance Officer of the Company after the end of working hours on Friday, 25th June 2021. This is for your information and record.
17-05-2021
Next Page
Close

Let's Open Free Demat Account